| 2022 Requests for Applications (RFA's) |
| RFA No. and Title | Status - Expiration |
|---|
| CA22-057 Basic/Translational Research on Health Disparities in Underrepresented People Living with HIV (PLWH) and Cancer (R21 Clinical Trial Not Allowed) | ACTIVE - DEC 16, 2023 |
| CA22-056 Basic/Translational Research on Health Disparities in Underrepresented People Living with HIV (PLWH) and Cancer (R01 Clinical Trial Not Allowed) | ACTIVE - DEC 16, 2023 |
| CA22-055 Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT) Centers (U54 Clinical Trial Not Allowed) | EXPIRED - NOV 22, 2022 |
| CA22-054 The Early Detection Research Network: Clinical Validation Centers (U01 Clinical Trial Optional) | EXPIRED - SEP 20, 2022 |
| CA22-053 Coordinating Center for Cannabis and Cannabinoid Use in Adult Cancer Patients During Treatment: Assessing Benefits and Harms (U24 Clinical Trial Not Allowed) | ACTIVE - FEB 18, 2023 |
| CA22-052 Cannabis and Cannabinoid Use in Adult Cancer Patients During Treatment: Assessing Benefits and Harms (U01 Clinical Trial Not Allowed) | ACTIVE - FEB 18, 2023 |
| CA22-051 Clinical Sites for HIV/Cervical Cancer Prevention 'CASCADE' Clinical Trials Network (UG1 Clinical Trial Required) | ACTIVE - DEC 29, 2022 |
| CA22-050 NCI Cancer Moonshot Scholars Diversity Program (CMSDP) (R01 Clinical Trial Optional) | ACTIVE - FEB 07, 2024 |
| CA22-046 Radiation Oncology-Biology Integration Network (ROBIN) Centers (U54 Clinical Trial Required) | EXPIRED - OCT 04, 2022 |
| CA22-045 NCI Outstanding Investigator Award (R35 Clinical Trial Optional) | ACTIVE - NOV 08, 2024 |
| CA22-043 Advancing Adolescent Tobacco Cessation Intervention Research (R01 Clinical Trial Required) | ACTIVE - OCT 17, 2023 |
| CA22-042 Advancing Adolescent Tobacco Cessation Intervention Research (R34 Clinical Trial Optional) | ACTIVE - OCT 17, 2023 |
| CA22-041 The NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00 Clinical Trial Not Allowed) | EXPIRED - NOV 19, 2022 |
| CA22-038 Limited Competition: Cancer Immune Monitoring and Analysis Centers (CIMACs) and Cancer Immunologic Data Center (CIDC) (U24 Clinical Trial Not Allowed) | EXPIRED - OCT 25, 2022 |
| CA22-037 NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Basic Experimental Studies with Humans Required) | ACTIVE - MAR 01, 2023 |
| CA22-036 NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Required) | ACTIVE - MAR 01, 2023 |
| CA22-035 NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Not Allowed) | ACTIVE - MAR 01, 2023 |
| CA22-032 Consortium on Translational Research in Early Detection of Liver Cancer: Data Management and Coordinating Center (U24 Clinical Trial Not Allowed) | EXPIRED - NOV 08, 2022 |
| CA22-031 Consortium on Translational Research in Early Detection of Liver Cancer: Translational Research Centers (U01 Clinical Trial Optional) | EXPIRED - NOV 08, 2022 |
| CA22-030 Cancer Adoptive Cellular Therapy Network (Can-ACT) Coordinating Center (U24 Clinical Trial Not Allowed) | EXPIRED - OCT 29, 2022 |
| CA22-029 Cancer Adoptive Cellular Therapy Network (Can-ACT) for Pediatric Cancers (UG3/UH3 Clinical Trial Required) | ACTIVE - JUL 01, 2023 |
| CA22-028 Cancer Adoptive Cellular Therapy Network (Can-ACT) for Adult Cancers (UG3/UH3 Clinical Trial Required) | ACTIVE - JUL 01, 2023 |
| CA22-027 Research to Understand and Address the Survivorship Needs of Individuals Living with Advanced Cancer (R01 Clinical Trial Optional) | ACTIVE - SEP 30, 2023 |
| CA22-026 Limited Competition: A Data Resource for Blood and Marrow Transplants and Adoptive Cellular Therapy Research (U24 Clinical Trial Not Allowed) | EXPIRED - SEP 16, 2022 |
| CA22-024 Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) | EXPIRED - NOV 18, 2022 |
| CA22-023 Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) | EXPIRED - NOV 18, 2022 |
| CA22-022 Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional) | EXPIRED - NOV 18, 2022 |
| CA22-021 Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21 Clinical Trial Optional) | EXPIRED - NOV 18, 2022 |
| CA22-019 Global Implementation Science for Equitable Cancer Control (GlobalISE Cancer Control, U54 Clinical Trial Optional) | EXPIRED - NOV 09, 2022 |
| CA22-016 Pediatric Immunotherapy Network (PIN) (U01 Clinical Trial Optional) | EXPIRED - SEP 28, 2022 |
| CA22-013 PDX Data Commons and Coordinating Center (PDCCC) for the PDX Development and Trial Centers Research Network (PDXNet) (U24 Clinical Trial Not Allowed) | EXPIRED - NOV 02, 2022 |
| CA22-012 Patient Derived Xenograft (PDX) Development and Trial Centers (PDTCs) Network (U54 Clinical Trial Not Allowed) | EXPIRED - NOV 02, 2022 |
| CA22-010 Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U2C Clinical Trial Optional) | EXPIRED - SEP 23, 2022 |
| CA22-009 Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional) | EXPIRED - SEP 23, 2022 |
| CA22-008 Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P01 Clinical Trial Optional) | EXPIRED - SEP 23, 2022 |
| CA22-007 Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U54 Clinical Trials Optional) | EXPIRED - SEP 23, 2022 |
| CA22-006 Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional) | EXPIRED - SEP 23, 2022 |
| CA22-005 Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional) | EXPIRED - SEP 23, 2022 |
| CA22-004 Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) | EXPIRED - SEP 23, 2022 |
| CA22-003 Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) | EXPIRED - SEP 23, 2022 |
| CA22-002 Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) | EXPIRED - SEP 23, 2022 |
| CA22-001 Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) | EXPIRED - SEP 23, 2022 |
